APA

Balasubramanian V., Domanskyi A., Renko J., Sarparanta M., Wang C., Correia A., Mäkilä E., Alanen O. S., Salonen J., Airaksinen A. J., Tuominen R., Hirvonen J., Airavaara M. & Santos H. A. (20210514). Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke. : Biomaterials.

Chicago

Balasubramanian Vimalkumar, Domanskyi Andrii, Renko Juho-Matti, Sarparanta Mirkka, Wang Chang-Fang, Correia Alexandra, Mäkilä Ermei, Alanen Osku S, Salonen Jarno, Airaksinen Anu J, Tuominen Raimo, Hirvonen Jouni, Airavaara Mikko and Santos Hélder A. 20210514. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke. : Biomaterials.

Harvard

Balasubramanian V., Domanskyi A., Renko J., Sarparanta M., Wang C., Correia A., Mäkilä E., Alanen O. S., Salonen J., Airaksinen A. J., Tuominen R., Hirvonen J., Airavaara M. and Santos H. A. (20210514). Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke. : Biomaterials.

MLA

Balasubramanian Vimalkumar, Domanskyi Andrii, Renko Juho-Matti, Sarparanta Mirkka, Wang Chang-Fang, Correia Alexandra, Mäkilä Ermei, Alanen Osku S, Salonen Jarno, Airaksinen Anu J, Tuominen Raimo, Hirvonen Jouni, Airavaara Mikko and Santos Hélder A. Engineered antibody-functionalized porous silicon nanoparticles for therapeutic targeting of pro-survival pathway in endogenous neuroblasts after stroke. : Biomaterials. 20210514.